Baxter International Inc., a $9.8 billion maker of treatments for complex medical conditions, named Robert Davis CFO and corporate vice president. He succeeds John Greisch, who was named president of international operations and corporate vice president. Davis, 39, joined the Deerfield, Ill.-based company in 2004 as treasurer and will retain the treasurer's position until a successor is named. Prior to his coming to Baxter, Davis held numerous financial positions at Eli Lilly & Co., including director of corporate financial planning, assistant treasurer, tax counsel and director of corporate tax planning.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.